Esoglaz 40 Tablet contains Esomeprazole 40 mg, a proton pump inhibitor (PPI) used primarily to reduce gastric acid secretion. It is indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, Zollinger-Ellison syndrome, and other conditions involving excessive stomach acid production. Esomeprazole acts by selectively inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby suppressing the final step of acid production. This results in decreased gastric acidity, promoting healing of acid-related damage and alleviating symptoms such as heartburn, acid regurgitation, and epigastric pain. Esoglaz 40 Tablet is typically administered orally once daily before meals, with dosage and duration tailored according to the specific condition and patient response. It is generally well tolerated; however, potential adverse effects may include headache, diarrhea, nausea, abdominal pain, and dizziness. Long-term use should be monitored due to risks such as vitamin B12 deficiency, hypomagnesemia, and increased susceptibility to gastrointestinal infections. Esomeprazole should be used cautiously in patients with hepatic impairment and contraindicated in individuals with known hypersensitivity to the drug or its components. Consultation with a healthcare professional is essential before initiating therapy with Esoglaz 40 Tablet.

Dosage & How to Use